Dominique Morel
Overview
Explore the profile of Dominique Morel including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
8
Citations
76
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Bowie A, Walker K, Bunnell G, Morel D, Minesi F, Belais R, et al.
Am J Primatol
. 2020 Nov;
83(1):e23217.
PMID: 33226162
Poaching and habitat destruction in the Congo Basin threaten African great apes including the bonobo (Pan paniscus), chimpanzees (Pan troglodytes), and gorillas (Gorilla spp.) with extinction. One way to combat...
2.
Brisou G, Manzoni D, Dalle S, Felman P, Morel D, Boubaya M, et al.
J Clin Lab Anal
. 2014 Mar;
29(2):153-61.
PMID: 24652675
Background: The rigorous cytological review by manual or automatic microscopic analysis is critical in the detection of circulating neoplastic cells, since their morphology as well as their count contributes to...
3.
Baseggio L, Geay M, Gazzo S, Berger F, Traverse-Glehen A, Ffrench M, et al.
Br J Haematol
. 2012 Jun;
158(4):489-98.
PMID: 22686190
The translocation t(14;18) and its t(2;18) and t(18,22) variants, which involve the BCL2 genetic hallmark for follicular lymphoma (FL), have been reported in several cases of chronic B-cell lymphoproliferative disease...
4.
Jallades L, Jourdy Y, Morel D, Goedert G, Baseggio L, Felman P
Eur J Haematol
. 2012 Jan;
89(1):94.
PMID: 22268565
No abstract available.
5.
Baseggio L, Traverse-Glehen A, Berger F, Ffrench M, Jallades L, Morel D, et al.
Mod Pathol
. 2011 Apr;
24(7):993-1003.
PMID: 21499231
Angioimmunoblastic T-cell lymphoma is immunologically defined by the expression of CD10 and the follicular helper T cell (T(FH)) markers such as CXCL13, programmed death-1 (PD-1) and inducible T-cell costimulator (ICOS)....
6.
Baseggio L, Traverse-Glehen A, Petinataud F, Callet-Bauchu E, Berger F, Ffrench M, et al.
Haematologica
. 2009 Dec;
95(4):604-12.
PMID: 20015887
Background: Classically, splenic marginal zone B-cell lymphoma is characterized by the absence of CD5 expression. Cases of apparent splenic marginal zone B-cell lymphoma showing CD5 expression, as diagnosed by blood...
7.
Traverse-Glehen A, Baseggio L, Bauchu E, Morel D, Gazzo S, Ffrench M, et al.
Blood
. 2007 Nov;
111(4):2253-60.
PMID: 18042795
The presence of circulating villous lymphocytes (VLs) in lymphoma patients usually points to splenic marginal zone B-cell lymphoma (SMZL), even if the VLs can be found occasionally in other small...
8.
Gazzo S, Baseggio L, Coignet L, Poncet C, Morel D, Coiffier B, et al.
Haematologica
. 2003 Jan;
88(1):31-8.
PMID: 12551824
Background And Objectives: Whole or partial trisomy 3 represents the most recurrent chromosomal abnormality occurring in marginal zone B-cell lymphoma (MZBCL), a distinct subtype of B-cell non-Hodgkin's lymphoma (NHL). By...